CCL2 and isolated hemihyperplasia: Given the observed spontaneous early modification and the known functional features of MCP-1, we hypothesize that MCP-1 besides a marker of regression, may also represent a potential therapeutic target to induce IH regression and control of vascular growth in other more serious angiogenic disorders.